Analysis

Dare Bioscience, Inc. (DARE) Stock Analysis

Dare Bioscience, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to DARE.

websiteDARE/analysis/DARE

Dare Bioscience, Inc.

Dare Bioscience, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to DARE.

Stock profile

Ticker

DARE

Asset type

Stock

Market cap

$32.5M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Dare Bioscience, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • DARE primary listing

Latest Dare Bioscience, Inc. news

Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV I...

Receipt of award notice for second $1.0 million tranche of NIAID funding brings total NIH funding award for DARE-HPV to $2.0 millionFunding award milestone follows Daré's announ...

Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-A...

Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved treatments DARE-HPV development is backed by a $...

Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update

Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing Commencement and Flora Sync LF5™ Comme...

Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026

Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14,

Research sections

Valuation

Review valuation context for Dare Bioscience, Inc..

Future growth

Review future growth context for Dare Bioscience, Inc..

Past performance

Review past performance context for Dare Bioscience, Inc..

Financial health

Review financial health context for Dare Bioscience, Inc..

Dividend

Review dividend context for Dare Bioscience, Inc..

Management

Review management context for Dare Bioscience, Inc..

Ownership

Review ownership context for Dare Bioscience, Inc..

Other information

Review other information context for Dare Bioscience, Inc..

Community

Review community context for Dare Bioscience, Inc..